Patent ID: 7737171

Claim:
A method of treating, excluding prevention, a disease or disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula IA: wherein; R 1 -R 2 are independently selected from hydrogen, C 1-6 -alk(en/yn)yl, C 3-8 -cycloalk(en)yl, and C 3-8 -cycloalk(en)yl-C 1-6 -alk(en/yn)yl or R 1 and R 2 together with the nitrogen form a 4-7 membered ring containing zero or one double bond, optionally said ring in addition to said nitrogen comprises one further heteroatom selected from nitrogen, oxygen and sulphur; R 3 -R 7 and R 9 -R 11 are independently selected from hydrogen, halogen, cyano, nitro, C 1-6 -alk(en/yn)yl, C 3-8 -cycloalk(en)yl, C 3-8 -cycloalk(en)yl-C 1-6 -alk(en/yn)yl, amino, C 1-6 -alk(en/yn)ylamino, di-(C 1-6 -alk(en/yn)yl)amino, C 1-6 -alk(en/yn)ylcarbonyl, aminocarbonyl, C 1-6 -alk(en/yn)ylaminocarbonyl, di-(C 1-6 -alk(en/yn)yl)aminocarbonyl, hydroxy, C 1-6 -alk(en/yn)yloxy, C 1-6 -alk (en/yn)ylthio, halo-C 1-6 -alk(en/yn)yl, halo-C 1-6 -alk(en/yn)ylsulfonyl, halo-C 1-6 -alk(en/yn)ylsulfanyl and C 1-6 -alk(en/yn)ylsulfonyl; R 8 is halogen; and R 13 is selected from hydrogen or C 1-6 -alk(en/yn)yl; or a pharmaceutically acceptable salt thereof; and said disease or disorder is selected from the group consisting of major depressive disorder, postnatal depression, dysthymia, depression associated with bipolar disorder, depression associated with Alzheimer's, depression associated with psychosis, depression associated with Parkinson's, general anxiety disorder, social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder, panic disorder, panic attacks, specific phobias, social phobia, agoraphobia, fibromyalgia syndrome, overall pain, back pain, shoulder pain, headache, pain while awake and during daily activities, attention deficit hyperactivity disorder, and stress urinary incontinence.